{"url_path":"/sec/pvct/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-022950-index.html","accession_number":"0001493152-26-022950","cik":"0000315545","ticker":"PVCT","issuer_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-022950-index.html","primary_entity_key":"0000315545","primary_entity_name":"PROVECTUS BIOPHARMACEUTICALS, INC."},"word_count":29,"has_tables":true,"body_markdown":"**ITEM\n1. LEGAL PROCEEDINGS.**\n\n \n\nThe\ninformation required by this item is incorporated by reference from Part I, Item 1. Financial Statements, Notes to Condensed Consolidated\nFinancial Statements, Note 13."}